亚洲药用植物治疗皮肤色素障碍的作用与机制
发现其通过MAPK、PKA等信号通路调节黑色素生成相关基因表达,部分成分促进、部分抑制色素合成,具临床价值但需进一步验证安全性与机制。
要点
- 药用植物活性成分可经MAPK、PKA通路双向调节黑色素生成。
- 异甘草素、栀子苷等促进色素合成,生物chanin A等抑制。
- 临床前证据支持用于色素障碍,但安全性与机制待明确。
核心结论
- 亚洲药用植物尤其活性成分通过调控黑色素生成相关基因或信号通路发挥多层次作用,对皮肤色素障碍有临床价值,但实验效应、安全性和功能机制需进一步确定。
主要发现
- 药用植物活性成分、提取物或复方可通过影响MAPK和PKA等信号通路调节黑色素生成相关基因表达,从而调控色素合成。
- 部分成分促进黑色素生成,如异甘草素、栀子苷、山茱萸、墨旱莲及八味地黄复方等。
- 另一些成分抑制黑色素生成,如biochanin A、Gomisin N、人参、甘松及三白汤等。
临床怎么用
- 可将药用植物活性成分视为皮肤色素障碍的潜在治疗策略,但临床使用前需进一步明确实验效应、安全性和功能机制。
局限性
- 药用植物的实验效应、安全性和功能机制尚需进一步确定,之后才能研究其临床疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Chloasma, senile plaques, vitiligo and other pigmentary disorders seriously affect patients' appearance and life quality. Medicinal plant is the product of long-term medical practice worldwide, with the advantages of outstanding curative properties and less side effects. Recently, research were made to explore the value of medicinal plants in the treatment of pigmentary disorders, and remarkable results were achieved. AIM OF THE REVIEW: This review outlines the current understanding of the role and potential mechanisms of medicinal plants (including active ingredients, extracts and prescriptions) in pigmentary disorders, especially Chinese medicinal plants, provides the preclinical evidence for the clinical benefits. This study hopes to provide comprehensive information and reliable basis for exploring new therapeutic strategies of plant drugs in the treatment of skin pigmented diseases. METHODS: The literature information was obtained from the scientific databases (up to Oct, 2017), mainly from the PubMed, Web of Science and CNKI databases, and was to identify the experimental studies on the regulating melanogenesis role of the active agents from herbal medicine and the involved mechanisms. The search keywords for such work included: "pigmentary" or "pigmentation", "melanogenesis", and "traditional Chinese medicine" or "Chinese herbal medicine", "herb", "medicinal plant". RESULTS: We summarized the function of medicinal plants involved in melanogenesis, especially Chinese medicine. It was reported that the active ingredients, extracts, or prescriptions of medicinal plants can regulate the expression of genes related to melanogenesis by affecting the signaling pathways such as MAPK and PKA, thereby regulating pigment synthesis. Some of them can promote melanogenesis (such as isoliquiritigenin, geniposide; Cornus officinalis Siebold & Zucc., Eclipta prostrata (L.) L.; the Bairesi complex prescription, etc.). While others have the opposite effect (such as biochanin A, Gomisin N; Panax ginseng C.A. Meyer, Nardostachys chinensis Bat.; Sanbaitang, etc.). CONCLUSION: Asian medicinal plants, especially their active ingredients, have multilevel effects on melanogenesis by regulating melanogenesis-related genes or signaling pathways. They are of great clinical value for the treatment of skin pigmentary disorders. However, the experimental effect, safety, and functional mechanism of the medicinal plants require further determination before studying their clinical efficacy.
引用
- Li Y, Huang J, Lu J, et al. The role and mechanism of Asian medicinal plants in treating skin pigmentary disorders. J Ethnopharmacol. 2019. PMID: 31445129. doi:10.1016/j.jep.2019.112173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。